Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAlterity Therapeutics Limited Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | $0.00 | $0.00 | $0.00 |
Alterity Therapeutics Limited Earnings Date And Information
Alterity Therapeutics Limited last posted its earnings results on N/A. The company reported $N/A earnings per share for the quarter, missing analysts' consensus estimates of $N/A by $0. The company had revenue of 2.12 M for the quarter and had revenue of 4.02 M for the year. Alterity Therapeutics Limited has generated $-3 earnings per share over the last year ($-3.14 diluted earnings per share) and currently has a price-to-earnings ratio of -1.27. Alterity Therapeutics Limited has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 3rd, 2025 based on prior year's report dates.
Alterity Therapeutics Limited Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/26/2024 | Q4 2024 | -$1.58 | $2.12 M | |||
| 12/29/2023 | Q2 2024 | -$1.56 | $1.90 M | |||
| 06/29/2023 | Q4 2023 | -$1.42 | $1.53 M | |||
| 12/30/2022 | Q2 2023 | -$2.00 | $2.39 M | |||
| 06/29/2022 | Q4 2022 | -$1.56 | $2.76 M | |||
| 12/30/2021 | Q2 2022 | -$1.64 | $2.36 M | |||
| 06/29/2021 | Q4 2021 | -$1.94 | $2.46 M | |||
| 12/30/2020 | Q2 2021 | -$3.88 | $1.88 M | |||
| 06/29/2020 | Q4 2020 | -$5.13 | $-1,855,172 | |||
| 03/30/2020 | Q3 2020 | -$2.54 | $-927,586 | |||
| 12/30/2019 | Q2 2020 | -$3.90 | $1.86 M | |||
| 09/29/2019 | Q1 2020 | -$1.95 | $927,586 | |||
| 06/29/2019 | Q4 2019 | -$6.05 | $2.52 M | |||
| 03/30/2019 | Q3 2019 | -$3.02 | $1.26 M | |||
| 12/30/2018 | Q2 2019 | -$5.97 | $2.43 M | |||
| 09/29/2018 | Q1 2019 | -$2.98 | $1.21 M | |||
| 06/29/2018 | Q4 2018 | -$5.22 | $1.65 M | |||
| 03/30/2018 | Q3 2018 | -$2.61 | $824,185 | |||
| 12/30/2017 | Q2 2018 | -$4.07 | $1.48 M | |||
| 09/29/2017 | Q1 2018 | -$2.03 | $738,703 |
Alterity Therapeutics Limited Earnings: FAQ's
When is Alterity Therapeutics Limited's earnings date?
Alterity Therapeutics Limited has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 3rd, 2025 based off last year's report dates.
How can I listen to Alterity Therapeutics Limited's earnings conference
call?
The conference call for Alterity Therapeutics Limited's latest earnings report can be listened to online.
How can I read Alterity Therapeutics Limited's conference call transcript?
The conference call transcript for Alterity Therapeutics Limited's latest earnings report can be read online.
How much revenue does Alterity Therapeutics Limited generate each year?
Alterity Therapeutics Limited (:ATHE) has a recorded annual revenue of $4.02 M.
How much profit does Alterity Therapeutics Limited generate each year?
Alterity Therapeutics Limited (:ATHE) has a recorded net income of $4.02 M. Alterity Therapeutics Limited has generated $-3.14 earnings per share over the last four quarters.
What is Alterity Therapeutics Limited's price-to-earnings ratio?
Alterity Therapeutics Limited (:ATHE) has a price-to-earnings ratio of -1.27 and price/earnings-to-growth ratio is -0.01.